WO1998043678A2 - Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy - Google Patents
Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy Download PDFInfo
- Publication number
- WO1998043678A2 WO1998043678A2 PCT/US1998/005858 US9805858W WO9843678A2 WO 1998043678 A2 WO1998043678 A2 WO 1998043678A2 US 9805858 W US9805858 W US 9805858W WO 9843678 A2 WO9843678 A2 WO 9843678A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrogen
- independently selected
- nitrogen
- sulfur
- hydroxyl
- Prior art date
Links
- 0 CS(C=C1*)C=C1NCCCNc1c[s]cc1N Chemical compound CS(C=C1*)C=C1NCCCNc1c[s]cc1N 0.000 description 2
- ROJXELIDXAIAFI-UHFFFAOYSA-N OC(CN(CCCN(CC(O)=O)C(CCCC1)C1C=C(CC(O1)=O)CC1=O)C1C(CCC(CC(O2)=O)CC2=O)CCCC1)=O Chemical compound OC(CN(CCCN(CC(O)=O)C(CCCC1)C1C=C(CC(O1)=O)CC1=O)C1C(CCC(CC(O2)=O)CC2=O)CCCC1)=O ROJXELIDXAIAFI-UHFFFAOYSA-N 0.000 description 1
- RTCIQTGBKSTEOL-UHFFFAOYSA-N OC(CN(CCCN(CC(O)=O)C(CCCC1)C1N(CC(O)=O)CC(O)=O)C(CCCC1)C1N(CC(O)=O)CC(O)=O)=O Chemical compound OC(CN(CCCN(CC(O)=O)C(CCCC1)C1N(CC(O)=O)CC(O)=O)C(CCCC1)C1N(CC(O)=O)CC(O)=O)=O RTCIQTGBKSTEOL-UHFFFAOYSA-N 0.000 description 1
- VCEMYBZJHPDKOH-UHFFFAOYSA-N OC(CN1C(CCC(C2)C(O)=O)C2SSC(CC(CC2)C(O)=O)C2N(CC(O)=O)CCC1)=O Chemical compound OC(CN1C(CCC(C2)C(O)=O)C2SSC(CC(CC2)C(O)=O)C2N(CC(O)=O)CCC1)=O VCEMYBZJHPDKOH-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic System
- C07F13/005—Compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/087—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/31—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton
- C07C323/33—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring
- C07C323/34—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atom of at least one of the thio groups bound to a carbon atom of a six-membered aromatic ring of the carbon skeleton having at least one of the nitrogen atoms bound to a carbon atom of the same non-condensed six-membered aromatic ring the thio group being a mercapto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/10—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
- C07D265/32—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
- C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
- C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
- C07F9/3817—Acids containing the structure (RX)2P(=X)-alk-N...P (X = O, S, Se)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE69837038T DE69837038T2 (de) | 1997-03-28 | 1998-03-26 | Tetraaza- oder n2s2-komplexanten, und deren verwendung in der radiodiagnostik oder radiotherapie |
EP98912032A EP0971748B1 (en) | 1997-03-28 | 1998-03-26 | Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
JP54176898A JP2002500629A (ja) | 1997-03-28 | 1998-03-26 | テトラアザ−またはN2S2−錯化剤(complexant)、および放射線診断または放射線治療におけるその使用 |
CA002284653A CA2284653C (en) | 1997-03-28 | 1998-03-26 | Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/829,533 US6005083A (en) | 1997-03-28 | 1997-03-28 | Bridged aromatic substituted amine ligands with donor atoms |
US08/829,533 | 1997-03-28 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO1998043678A2 true WO1998043678A2 (en) | 1998-10-08 |
WO1998043678A3 WO1998043678A3 (en) | 1999-03-04 |
WO1998043678B1 WO1998043678B1 (en) | 1999-04-01 |
Family
ID=25254797
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1998/005858 WO1998043678A2 (en) | 1997-03-28 | 1998-03-26 | Tetraaza- or n2s2- complexants, and their use in radiodiagnostics or radiotherapy |
Country Status (7)
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000002587A1 (en) * | 1998-07-13 | 2000-01-20 | Board Of Regents, The University Of Texas System | Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
US6406693B1 (en) | 1998-07-13 | 2002-06-18 | Board Of Regents, The University Of Texas System | Cancer treatment methods using antibodies to aminophospholipids |
US6818213B1 (en) | 1998-07-13 | 2004-11-16 | Board Of Regents, The University Of Texas System | Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids |
US7112317B2 (en) | 1992-03-05 | 2006-09-26 | Board Of Regents, The University Of Texas System | Combined methods and compositions for tumor vasculature targeting and tumor treatment |
US8044081B2 (en) | 2001-02-16 | 2011-10-25 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Aminoderivative of biotin and their conjugates with macrocyclic chelating agents |
US8486391B2 (en) | 1998-07-13 | 2013-07-16 | Board Of Regents, University Of Texas System | Cancer treatment kits using antibodies to aminophospholipids |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6005083A (en) * | 1997-03-28 | 1999-12-21 | Neorx Corporation | Bridged aromatic substituted amine ligands with donor atoms |
US6239237B1 (en) * | 1999-04-22 | 2001-05-29 | Nova Chemicals (International) S.A. | Group 8, 9 or 10 transition metal catalyst for olefin polymerization |
AU5871000A (en) | 1999-06-11 | 2001-01-02 | Paul G. Abrams | High dose radionuclide complexes for bone marrow suppression |
US7094885B2 (en) | 1999-07-11 | 2006-08-22 | Neorx Corporation | Skeletal-targeted radiation to treat bone-associated pathologies |
US7067111B1 (en) | 1999-10-25 | 2006-06-27 | Board Of Regents, University Of Texas System | Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
US6565828B2 (en) * | 2000-04-07 | 2003-05-20 | Bristol-Myers Squibb Company | Macrocyclic chelants for metallopharmaceuticals |
EP1286704B1 (en) | 2000-06-02 | 2014-07-23 | Board of Regents, The University of Texas System | ETHYLENEDICYSTEINE (EC)-glucose analog CONJUGATES |
WO2002062398A2 (en) | 2001-01-08 | 2002-08-15 | Neorx Corporation | Radioactively labelled conjugates of phosphonates |
DE10125258A1 (de) * | 2001-05-23 | 2003-01-09 | November Ag Molekulare Medizin | Verfahren zur Bestimmung des Bindeverhaltens von an Ziel-Molekülen spezifisch bindenden Liganden |
US6890513B2 (en) | 2001-05-25 | 2005-05-10 | Mcmaster University | Metal-carborane complexes for radioimaging and radiotherapy and methods for their preparation |
AU2003256334A1 (en) * | 2002-07-01 | 2004-01-19 | Pharmacia And Upjohn Company | Inhibitors of hcv ns5b polymerase |
US9050378B2 (en) | 2003-12-10 | 2015-06-09 | Board Of Regents, The University Of Texas System | N2S2 chelate-targeting ligand conjugates |
US8758723B2 (en) | 2006-04-19 | 2014-06-24 | The Board Of Regents Of The University Of Texas System | Compositions and methods for cellular imaging and therapy |
US10925977B2 (en) | 2006-10-05 | 2021-02-23 | Ceil>Point, LLC | Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5021571A (en) * | 1989-06-29 | 1991-06-04 | Associated Universities, Inc. | Cyclohexyl EDTA monoanhydride |
EP0603403A1 (en) * | 1992-07-03 | 1994-06-29 | The Green Cross Corporation | Novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound |
US5334729A (en) * | 1989-06-29 | 1994-08-02 | Associated Universities, Inc. | Stable radiometal antibody immunoconjugates |
US5362475A (en) * | 1981-07-24 | 1994-11-08 | Schering Aktiengesellschaft | Gadolinium chelates for magnetic resonance imaging |
WO1994026754A1 (en) * | 1993-05-06 | 1994-11-24 | The Dow Chemical Company | Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
WO1995032192A1 (en) * | 1994-05-19 | 1995-11-30 | Neorx Corporation | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging |
WO1997001360A2 (en) * | 1995-06-26 | 1997-01-16 | Concat, Ltd. | Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
US5676928A (en) * | 1994-03-28 | 1997-10-14 | Nycomed Imaging As | Liposomes |
WO1998004294A2 (en) * | 1996-07-26 | 1998-02-05 | Neorx Corporation | Radiolabeled annexins |
Family Cites Families (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2977279A (en) * | 1955-11-29 | 1961-03-28 | Monsanto Chemicals | Copper chelate coordination complexes |
US3027391A (en) * | 1959-08-28 | 1962-03-27 | Norman A Frigerio | Metal phthalocyanines |
US4088747A (en) * | 1975-02-19 | 1978-05-09 | Australian Atomic Energy Commission | Phenolic amino-carboxylic acid radiopharmaceuticals |
DE2616984C3 (de) * | 1976-04-17 | 1981-10-29 | Behringwerke Ag, 3550 Marburg | Verfahren zur Isolierung und Reinigung eines plazentenspezifischen Glycoproteins |
JPS5486602A (en) * | 1977-10-27 | 1979-07-10 | Hoffmann La Roche | Production of purified alpha 1 phetoprotein |
US4293537A (en) * | 1978-09-05 | 1981-10-06 | Wong Dennis W | Novel chemical method of labeling proteins with 99m Tc-Technetium at physiological condition |
JPS567725A (en) * | 1979-06-28 | 1981-01-27 | Daiichi Rajio Isotope Kenkyusho:Kk | Tumor scanning agent |
US4421735A (en) * | 1980-04-17 | 1983-12-20 | The Massachusetts General Hospital | Radiolabeled diagnostic compositions and method for making the same |
US4385046A (en) * | 1980-12-15 | 1983-05-24 | Minnesota Mining And Manufacturing Company | Diagnostic radio-labeled polysaccharide derivatives |
US5648063A (en) * | 1981-07-24 | 1997-07-15 | Schering Aktiengesellschaft | Sterile composition comprising a chelate complex for magnetic resonance imaging |
US4452774A (en) * | 1982-04-30 | 1984-06-05 | President And Fellows Of Harvard College | Isonitrile radionuclide complexes for labelling and imaging agents |
DE3228503A1 (de) * | 1982-07-30 | 1984-02-02 | Behringwerke Ag, 3550 Marburg | Neues protein (pp(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)7(pfeil abwaerts)), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung |
US4758682A (en) * | 1983-03-17 | 1988-07-19 | California Institute Of Technology | Homogeneous coordination compounds as oxidation catalysts |
DE3315000A1 (de) * | 1983-04-26 | 1984-10-31 | Behringwerke Ag, 3550 Marburg | Gewebeprotein pp(pfeil abwaerts)4(pfeil abwaerts), verfahren zu seiner gewinnung sowie seine verwendung |
US4515767A (en) * | 1983-06-20 | 1985-05-07 | The Dow Chemical Company | Radioactive metals complexed with phosphonate derivatives of dicyclopentadienebis(methylamine) |
US4673562A (en) * | 1983-08-19 | 1987-06-16 | The Children's Medical Center Corporation | Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents |
US4560548A (en) * | 1984-04-10 | 1985-12-24 | The Dow Chemical Company | Bone seeking Tc-99m complexes of phosphonate derivatives of bis(aminoalkyl)piperazine |
AU4311085A (en) * | 1984-06-01 | 1985-12-05 | E.I. Du Pont De Nemours And Company | Copper salt and ligand containing composition |
US5064633A (en) * | 1984-06-04 | 1991-11-12 | The Dow Chemical Company | Macrocyclic aminophosphonic acid complexes, their formulations and use |
US5059412A (en) * | 1984-06-04 | 1991-10-22 | The Dow Chemical Company | Macrocyclic aminophosphonic acid complexes for the treatment of calcific tumors |
US5066478A (en) * | 1984-06-04 | 1991-11-19 | The Dow Chemical Company | Radio labeled organic amine phosphonic acid complexes for the treatment of calcific tumors |
US4898724A (en) * | 1984-06-04 | 1990-02-06 | The Dow Chemical Company | Organis amine phosphonic acid complexes for the treatment of calcific tumors |
US4963688A (en) * | 1984-07-19 | 1990-10-16 | University Of Florida | Compounds for site-enhanced delivery of radionuclides and uses thereof |
US4963682A (en) * | 1984-07-19 | 1990-10-16 | University Of Florida | Novel radiopharmaceuticals and chelating agents useful in their preparation |
US4722892A (en) * | 1984-08-31 | 1988-02-02 | Meares Claude F | Monoclonal antibodies against metal chelates |
US4897254A (en) * | 1984-09-21 | 1990-01-30 | The Dow Chemical Company | Radioactive compositions for the treatment of calcific tumors |
GB8426845D0 (en) * | 1984-10-24 | 1984-11-28 | Amersham Int Plc | Complexes of technetium-99m |
US5019497A (en) * | 1984-11-09 | 1991-05-28 | Lennart Olsson | Human squamous lung carcinoma cell specific antigens and antibodies |
US4897255A (en) * | 1985-01-14 | 1990-01-30 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
US5242679A (en) * | 1985-01-14 | 1993-09-07 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
US5175343A (en) * | 1985-01-14 | 1992-12-29 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
US5120526A (en) * | 1985-01-14 | 1992-06-09 | Neorx Corporation | Method of producing metal radionuclide labeled proteins for diagnosis and therapy |
US5037630A (en) * | 1985-01-14 | 1991-08-06 | Neorx Corporation | Metal radionuclide labeled proteins for diagnosis and therapy |
DE3687467T2 (de) * | 1985-03-11 | 1993-04-29 | Amersham Int Plc | Komplexe von technetium-99m mit propylen-amin-oximen. |
US4746505A (en) * | 1985-04-26 | 1988-05-24 | President And Fellows Of Harvard College | Technetium radiodiagnostic fatty acids derived from bisamide bisthiol ligands |
EP0200211A1 (en) * | 1985-05-01 | 1986-11-05 | The Research Foundation Of State University Of New York | Diagnostic radiopharmaceutical compounds |
US5225181A (en) * | 1985-06-07 | 1993-07-06 | The Research Foundation Of State University Of New York | Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi |
US4831122A (en) * | 1986-01-09 | 1989-05-16 | Regents Of The University Of Minnesota | Radioimmunotoxins |
US5271927A (en) * | 1986-02-13 | 1993-12-21 | Celltech Limited | Antibody conjugates with macrocyclic ligands |
US4732974A (en) * | 1986-03-05 | 1988-03-22 | Mallinckrodt, Inc. | Metal ion labeling of carrier molecules |
US4877868A (en) * | 1986-03-12 | 1989-10-31 | Neorx Corporation | Radionuclide antibody coupling |
US4861869A (en) * | 1986-05-29 | 1989-08-29 | Mallinckrodt, Inc. | Coupling agents for joining radionuclide metal ions with biologically useful proteins |
US4863713A (en) * | 1986-06-23 | 1989-09-05 | The Board Of Trustees Of Leland Stanford Jr. Univ. | Method and system for administering therapeutic and diagnostic agents |
US4859431A (en) | 1986-11-10 | 1989-08-22 | The Curators Of The University Of Missouri | Rhenium generator system and its preparation and use |
ES2053517T3 (es) * | 1986-12-30 | 1994-08-01 | Nihon Mediphysics Co Ltd | Compuesto de elevado peso molecular que comprende una unidad de un compuesto dirigido hacia el aceotir asialoglicoproteinico y una unidad de un compuesto que forma un quelato ligado quimicamente a este y su utilizacion. |
US5279811A (en) * | 1987-02-18 | 1994-01-18 | The Du Pont Merck Pharmaceutical Company | Ester-substituted diaminedithiols and radiolabeled complexes thereof |
US5091514A (en) * | 1987-03-26 | 1992-02-25 | Neorx Corporation | Metal-radionuclide-labeled proteins and glycoproteins for diagnosis and therapy |
AR246956A1 (es) * | 1987-05-08 | 1994-10-31 | Salutar Inc | Compuesto quelante, un intermediario para preparar el mismo, y un procedimiento para preparar una composicion de medio de contraste. |
US4853209A (en) * | 1987-05-18 | 1989-08-01 | The Dow Chemical Company | Bone marrow suppressing agents |
US5167948A (en) * | 1987-08-07 | 1992-12-01 | Mallinckrodt Medical, Inc. | Diagnostic or radiotherapeutic composition comprising a hydrogen containing compound |
ATE89271T1 (de) * | 1987-11-19 | 1993-05-15 | Univ Vanderbilt | Radiojodhaltige benzamide und verfahren zu ihrer verwendung als radiobildende agenzien. |
US5322678A (en) * | 1988-02-17 | 1994-06-21 | Neorx Corporation | Alteration of pharmacokinetics of proteins by charge modification |
EP0329184A3 (en) * | 1988-02-19 | 1990-05-23 | Neorx Corporation | Antimers and antimeric conjugation |
US5112954A (en) * | 1988-02-26 | 1992-05-12 | Neorx Corporation | Method of enhancing the effect of cytotoxic agents |
US5061641A (en) * | 1988-04-01 | 1991-10-29 | Immunomedics, Inc. | Method for radiolabeling proteins |
US5057301A (en) * | 1988-04-06 | 1991-10-15 | Neorx Corporation | Modified cellular substrates used as linkers for increased cell retention of diagnostic and therapeutic agents |
US5059541A (en) * | 1988-04-29 | 1991-10-22 | Neorx Corporation | Minimal derivatization of proteins |
US5075099A (en) * | 1988-05-31 | 1991-12-24 | Neorx Corporation | Metal radionuclide chelating compounds for improved chelation kinetics |
CA1340527C (en) * | 1988-05-31 | 1999-05-04 | Lidia Vallarino | Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
US5089249A (en) * | 1988-06-10 | 1992-02-18 | Neorx Corporation | Conjugates for bone imaging and bone cancer therapy |
US5002754A (en) * | 1988-06-15 | 1991-03-26 | University Of Cincinnati | Technetium (III/II) imaging agents |
US5071965A (en) * | 1988-07-19 | 1991-12-10 | Mallinckrodt Medical, Inc. | Novel tc-99m complexes |
US5169933A (en) * | 1988-08-15 | 1992-12-08 | Neorx Corporation | Covalently-linked complexes and methods for enhanced cytotoxicity and imaging |
US5252713A (en) * | 1988-09-23 | 1993-10-12 | Neorx Corporation | Polymeric carriers for non-covalent drug conjugation |
US4987227A (en) * | 1988-10-21 | 1991-01-22 | The Research Foundation Of State University Of New York | Polyazamacrocycles and their metal complexes |
US4925650A (en) * | 1988-11-16 | 1990-05-15 | Mallinckrodt, Inc. | Technetium -99m complex for examining the renal function |
US4976950A (en) * | 1988-12-19 | 1990-12-11 | The Dow Chemical Company | Bone marrow suppressing agents |
US5053503A (en) * | 1989-02-17 | 1991-10-01 | Centocor | Chelating agents |
US4959304A (en) * | 1989-05-22 | 1990-09-25 | United States Of America As Represented By The Secretary Of The Navy | Production of monoclonal antibodies to treponema denticola by hybridoma TDIII, IIIBB2 |
US5164176A (en) * | 1989-06-16 | 1992-11-17 | Neorx Corporation | Radionuclide metal chelates for the radiolabeling of proteins |
US5250666A (en) * | 1989-06-16 | 1993-10-05 | Neorx Corporation | Radionuclide metal chelates for the radiolabeling of proteins |
DE3930674A1 (de) * | 1989-09-11 | 1991-03-21 | Diagnostikforschung Inst | Bifunktionelle chelatbildner zur komplexierung von tc- und re-isotopen, verfahren zu ihrer herstellung und darstellung von konjugaten daraus sowie deren verwendung in diagnostik und therapie |
US5053186A (en) | 1989-10-02 | 1991-10-01 | Neorx Corporation | Soluble irradiation targets and methods for the production of radiorhenium |
US5026913A (en) * | 1989-12-12 | 1991-06-25 | Medi-Physics, Inc. | Hydrocarbylphenyl diaminodithiol derivatives |
US5080884A (en) * | 1989-12-12 | 1992-01-14 | Medi-Physics, Inc. | Hydrocarbylphenyl diaminodithiol radionuclide complexes and their use in imaging |
ATE101596T1 (de) * | 1989-12-12 | 1994-03-15 | Amersham Int Plc | Phenyldiaminodithiolderivate. |
US5112953A (en) * | 1989-12-29 | 1992-05-12 | Neorx Corporation | Radiolabeled proteins for diagnostic or therapeutic use |
US5175257A (en) * | 1989-12-29 | 1992-12-29 | Neorx Corporation | Radiolabeled proteins for diagnostic or therapeutic use |
US5079346A (en) * | 1990-05-01 | 1992-01-07 | Trustees Of The University Of Pennsylvania | Gallium-labelled imaging agents |
US5286848A (en) * | 1990-05-07 | 1994-02-15 | Hamamatsu Photonics K.K. | Lanthanide cryptate of trisphenanthroline |
ES2108048T3 (es) * | 1990-08-29 | 1997-12-16 | Genpharm Int | Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos. |
US5382654A (en) * | 1992-02-05 | 1995-01-17 | Mallinckrodt Medical, Inc. | Radiolabelled peptide compounds |
US5104638A (en) * | 1990-10-29 | 1992-04-14 | Mallinckrodt Medical, Inc. | Method of making a radiopharmaceutical complex from a kit |
US5116598A (en) * | 1990-10-29 | 1992-05-26 | Mallinckrodt Medical, Inc. | N4 technetium-99 m complexes for use as radiopharmaceuticals |
US5243073A (en) * | 1990-12-14 | 1993-09-07 | Mallinckrodt Medical, Inc. | Hexadentate ligands useful in radiographic imaging agents |
US5112594A (en) * | 1991-04-04 | 1992-05-12 | Mallinckrodt Medical, Inc. | Kit for preparing a technetium-99m myocardial imaging agent |
US5112595A (en) * | 1990-12-21 | 1992-05-12 | Mallinckrodt Medical, Inc. | 99MTC(III) myocardial imaging agents and method of use |
US5133956A (en) * | 1991-05-30 | 1992-07-28 | The Dow Chemical Company | Radiolabeled metal-binding protein for the treatment of arthritis |
IT1248361B (it) | 1991-06-28 | 1995-01-05 | Enea | Vettori plasmidici per l'espressione di geni in piante |
US5330737A (en) * | 1991-12-06 | 1994-07-19 | Mallinckrodt Medical, Inc. | Nitrogen-sulfur ligands as opiate receptor drug mimics |
US5220000A (en) * | 1992-01-23 | 1993-06-15 | Spyros Theodoropulos | Bifunctional-bis-quinolinols, and their metal chelates |
US5371184A (en) * | 1992-02-05 | 1994-12-06 | Mallinckrodt Medical, Inc. | Radiolabelled peptide compounds |
DE69330494T2 (de) * | 1992-02-05 | 2002-03-28 | Mallinckrodt Inc | Radioaktiv markierte somatostatin |
US5310536A (en) * | 1992-02-06 | 1994-05-10 | Mallinckrodt Medical, Inc. | Ligands for improving metal chelate formation kinetics |
US5324502A (en) * | 1992-04-02 | 1994-06-28 | Purdue Research Foundation | Radiopharmaceuticals for imaging the heart |
US5319143A (en) * | 1992-07-31 | 1994-06-07 | Polaroid Corporation | Bis(aminoethanethiols) |
US5476644A (en) * | 1994-04-13 | 1995-12-19 | Sterling Winthrop Inc. | Cyclic triamine chelating agents |
CA2190727C (en) * | 1994-05-19 | 2006-07-18 | Sudhakar Kasina | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging |
US5508458A (en) * | 1995-05-26 | 1996-04-16 | Hoechst Celanese Corporation | Chiral catalysts and processes for preparing the same |
US6005083A (en) * | 1997-03-28 | 1999-12-21 | Neorx Corporation | Bridged aromatic substituted amine ligands with donor atoms |
-
1997
- 1997-03-28 US US08/829,533 patent/US6005083A/en not_active Expired - Lifetime
-
1998
- 1998-03-26 JP JP54176898A patent/JP2002500629A/ja not_active Ceased
- 1998-03-26 EP EP07001523A patent/EP1813607A3/en not_active Withdrawn
- 1998-03-26 DE DE69837038T patent/DE69837038T2/de not_active Expired - Lifetime
- 1998-03-26 WO PCT/US1998/005858 patent/WO1998043678A2/en active IP Right Grant
- 1998-03-26 EP EP98912032A patent/EP0971748B1/en not_active Expired - Lifetime
- 1998-03-26 CA CA002284653A patent/CA2284653C/en not_active Expired - Fee Related
- 1998-03-26 ES ES98912032T patent/ES2281927T3/es not_active Expired - Lifetime
-
1999
- 1999-05-12 US US09/310,455 patent/US6187910B1/en not_active Expired - Fee Related
- 1999-05-12 US US09/310,900 patent/US6177551B1/en not_active Expired - Fee Related
-
2000
- 2000-11-28 US US09/724,834 patent/US6528627B1/en not_active Expired - Fee Related
-
2003
- 2003-01-17 US US10/346,311 patent/US6936700B2/en not_active Expired - Fee Related
-
2005
- 2005-02-18 US US11/061,110 patent/US7268220B2/en not_active Expired - Fee Related
-
2007
- 2007-09-04 US US11/849,769 patent/US7674886B2/en not_active Expired - Fee Related
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5362475A (en) * | 1981-07-24 | 1994-11-08 | Schering Aktiengesellschaft | Gadolinium chelates for magnetic resonance imaging |
US5021571A (en) * | 1989-06-29 | 1991-06-04 | Associated Universities, Inc. | Cyclohexyl EDTA monoanhydride |
US5334729A (en) * | 1989-06-29 | 1994-08-02 | Associated Universities, Inc. | Stable radiometal antibody immunoconjugates |
EP0603403A1 (en) * | 1992-07-03 | 1994-06-29 | The Green Cross Corporation | Novel chelating agent, complex compound composed of said agent and metallic atom, and diagnostic agent containing said compound |
WO1994026754A1 (en) * | 1993-05-06 | 1994-11-24 | The Dow Chemical Company | Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation |
US5676928A (en) * | 1994-03-28 | 1997-10-14 | Nycomed Imaging As | Liposomes |
WO1995032192A1 (en) * | 1994-05-19 | 1995-11-30 | Neorx Corporation | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging |
WO1997001360A2 (en) * | 1995-06-26 | 1997-01-16 | Concat, Ltd. | Compounds with chelation affinity and selectivity for first transition series elements and their use in medical therapy and diagnosis |
WO1998004294A2 (en) * | 1996-07-26 | 1998-02-05 | Neorx Corporation | Radiolabeled annexins |
Non-Patent Citations (23)
Title |
---|
"Indium-111" REYNOLDS J E F (ED ): MARTINDALE - THE EXTRA PHARMACOPOEIA, ED. 31,1996, page 1465 XP002074823 Royal Pharmaceutical Society, London, GB * |
"Rhenium-186, Samarium-153, Technetium-99m, Yttrium-90" REYNOLDS J E F (ED ): MARTINDALE - THE EXTRA PHARMACOPOEIA, ED. 31,1996, pages 1467-1468, XP002074822 Royal Pharmaceutical Society, London, GB * |
BLANKENBERG F G ET AL: "Increased localization of Tc-99m hydrazino nicotinamide (HYNIC) labeled annexin V lipocortin in lymphatic tissue of animals treated with dexamethasone" JOURNAL OF NUCLEAR MEDICINE, 1997, VOL. 38, NO. 5 SUPPL., PAGE(S) 268P-269P., XP002084594 & 44TH ANNUAL MEETING OF THE SOCIETY OF NUCLEAR MEDICINE, SAN ANTONIO, TEXAS, USA, JUNE 1-5, 1997, * |
DEWANJEE M.K.: "Localization of 113m-In- and 67-Ga-labeled poly- methylene- phosphonates in myocardial infarct" NUKL. MED., 1977, VOL. 16, NO. 4, PAGE(S) 151-156, XP002084588 * |
GOECKELER W.F. ET AL: "Skeletal localization of samarium-153 chelates: Potential therapeutic bone agents" J. NUCL. MED., 1987, VOL. 28, NO. 4, PAGE(S) 495-504, XP002084591 * |
KASINA S ET AL: "Preformed chelate Tc-99m radiolabeling of r-annexin V for arterial thrombus imaging" JOURNAL OF NUCLEAR MEDICINE, 1996, VOL. 37, NO. 5 SUPPL., PAGE(S) 29P., XP002084593 & 43RD ANNUAL MEETING OF THE SOCIETY OF NUCLEAR MEDICINE, DENVER, COLORADO, USA, JUNE 3-5, 1996, * |
LEVER S Z ET AL: "PULMONARY ACCUMULATION OF NEUTRAL DIAMINE DITHIOL COMPLEXES OF TECHNETIUM-99M" JOURNAL OF PHARMACEUTICAL SCIENCES, vol. 83, no. 6, 1 June 1994, pages 802-809, XP000446373 * |
LOUW W K A ET AL: "Evaluation of Samarium-153 and Holmium-166-EDTMP in the Normal Baboon Model" NUCLEAR MEDICINE AND BIOLOGY, vol. 23, no. 8, November 1996, page 935-940 XP004073001 * |
PAPADOPOULOS M ET AL: "99MTC-DADT COMPLEXES SUBSTITUTED WITH HETEROCYCLIC AMINES: EFFECT OF SUBSTITUTION ON IN VIVO REACTIVITY" NUCLEAR MEDICINE AND BIOLOGY, vol. 20, no. 1, 1 January 1993, pages 105-115, XP000336597 * |
RENN O ET AL: "New approaches to delivering metal-labeled antibodies to tumors: Synthesis and characterization of new biotinyl chelate conjugates for pre-targeted diagnosis and therapy" JOURNAL OF CONTROLLED RELEASE, vol. 39, no. 2, May 1996, page 239-249 XP004037330 * |
S. BUDAVARI ET AL.: "THE MERCK INDEX, AN ENCYCLOPEDIA OF CHEMICALS, DRUGS, AND BIOLOGICALS" 1996 , MERCK & CO, INC , WHITEHOUSE STATION, US XP002074824 see page 1556, paragraph 9256 - page 1557, paragraph 9261 * |
SCHOMACKER K ET AL: "ÄThe effect of ethylenediaminetetramethylenephosphonate on the biodistribution of tumor-seeking radionuclidesÜ" NUKLEARMEDIZIN, FEB 1993, VOL. 32, NO. 1, PAGE(S) 23-6, XP002084587 * |
SCHOMACKER K ET AL: "Influence on extratumoral organ activities of tumor-affinity samarium-153 preparationsÜ" NUKLEARMEDIZIN, MAR 1997, VOL. 36, NO. 2, PAGE(S) 47-51, XP002084586 * |
STAHL W ET AL: "99m Technetium labelling of antibodies using methylphosphonylated, bifunctional cyclams as chelators" BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, VOL. 4, NO. 21, PAGE(S) 2597-2600., XP002084592 * |
STRATTON J R ET AL: "SELECTIVE UPTAKE OF RADIOLABELED ANNEXIN V ON ACUTE PORCINE LEFT ATRIAL THROMBI" CIRCULATION, vol. 92, no. 10, 15 November 1995, pages 3113-3121, XP002058828 * |
SUBRAMANIAN G ET AL: "Indium-113m-labeled polyfunctional phosphonates as bone-imaging agents." J NUCL MED, NOV 1975, VOL. 16, NO. 11, PAGE(S) 1080-4, XP002084585 * |
SUBRAMANIAN K M ET AL: "A NEW RADIOCHEMICAL METHOD TO DETERMINE THE STABILITY CONSTANTS OF METAL CHELATES ATTACHED TO A PROTEIN" JOURNAL OF NUCLEAR MEDICINE, vol. 31, no. 4, 1 April 1990, pages 480-488, XP000128746 * |
SUN Y: "TARGETING RADIOPHARMACEUTICALS-II. EVALUATION OF NEW TRIVALENT METAL COMPLEXES WITH DIFFERENT OVERALL CHARGES" INTERNATIONAL JOURNAL OF RADIATION APPLICATIONS AND INSTRUMENTATION PART B: NUCLEAR MEDICINE AND BIOLOGY, vol. 18, no. 3, 1 January 1991, pages 323-330, XP000215616 * |
TADASHI FUJISAWA ET AL: "CRITICAL CURRENT DENSITIES IN SUPERCONDUCTING Y-BA-CU-O PREPARED BY CHELATING METHOD" JAPANESE JOURNAL OF APPLIED PHYSICS, vol. 29, no. 10, 1 October 1990, pages 1914-1917, XP000223980 * |
TSIEN R Y: "New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures" BIOCHEMISTRY 1980, VOL. 19, NO. 11, PAGE(S) 2396-2404, XP002074821 * |
VOLKERT W A ET AL: "SKELETAL UPTAKE PROPERTIES OF TECHNETIUM-99M-LABELED MULTIDENTATE PHOSPHONATE LIGANDS" J LABELLED COMPD RADIOPHARM, 1984, VOL. 21, NO. 11-12, PAGE(S) 1063-1065, XP002084589 & 5TH INTERNATIONAL SYMPOSIUM ON RADIOPHARMACEUTICAL CHEMISTRY, TOKYO, JAPAN, JULY 9-13, 1984, * |
VOLKERT W.A. ET AL: "In vivo skeletal localization properties of 99m-Tc complexes of large phosphonate ligands" NUCL. MED. BIOL., 1986, VOL. 13, NO. 1, PAGE(S) 31-37, XP002084590 * |
WU C ET AL: "INVESTIGATIONS OF N-LINKED MACROCYCLES FOR 111IN AND 90Y LABELING OF PROTEINS" INTERNATIONAL JOURNAL OF RADIATION APPLICATIONS AND INSTRUMENTATION PART B: NUCLEAR MEDICINE AND BIOLOGY, vol. 19, no. 2, 1992, pages 239-244, XP002064857 * |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7112317B2 (en) | 1992-03-05 | 2006-09-26 | Board Of Regents, The University Of Texas System | Combined methods and compositions for tumor vasculature targeting and tumor treatment |
US7125541B2 (en) | 1992-03-05 | 2006-10-24 | The University Of Texas System Board Of Regents | Combined methods for tumor vasculature targeting and tumor treatment with radiotherapy |
US6818213B1 (en) | 1998-07-13 | 2004-11-16 | Board Of Regents, The University Of Texas System | Cancer treatment compositions comprising therapeutic conjugates that bind to aminophospholipids |
WO2000002587A1 (en) * | 1998-07-13 | 2000-01-20 | Board Of Regents, The University Of Texas System | Cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
US7067109B1 (en) | 1998-07-13 | 2006-06-27 | Board Of Regents, The University Of Texas System | Cancer treatment kits comprising therapeutic conjugates that bind to aminophospholipids |
US6783760B1 (en) | 1998-07-13 | 2004-08-31 | Board Of Regents, The University Of Texas System | Combined cancer treatment methods using therapeutic conjugates that bind to aminophospholipids |
US6406693B1 (en) | 1998-07-13 | 2002-06-18 | Board Of Regents, The University Of Texas System | Cancer treatment methods using antibodies to aminophospholipids |
US7422738B2 (en) | 1998-07-13 | 2008-09-09 | Board Of Regents, The University Of Texas System | Combined cancer treatment methods using antibodies to aminophospholipids |
US7550141B2 (en) | 1998-07-13 | 2009-06-23 | Board Of Regents, The University Of Texas System | Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids |
US7790860B2 (en) | 1998-07-13 | 2010-09-07 | Board Of Regents, The University Of Texas System | Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids |
US8486391B2 (en) | 1998-07-13 | 2013-07-16 | Board Of Regents, University Of Texas System | Cancer treatment kits using antibodies to aminophospholipids |
US8709430B2 (en) | 1998-07-13 | 2014-04-29 | Board Of Regents, The University Of Texas System | Cancer treatment kits comprising therapeutic antibody conjugates that bind to aminophospholipids |
US9795673B2 (en) | 1998-07-13 | 2017-10-24 | Board Of Regents, The University Of Texas System | Treating macular degeneration using antibodies to aminophospholipids |
US8044081B2 (en) | 2001-02-16 | 2011-10-25 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Aminoderivative of biotin and their conjugates with macrocyclic chelating agents |
Also Published As
Publication number | Publication date |
---|---|
DE69837038T2 (de) | 2007-07-12 |
US6187910B1 (en) | 2001-02-13 |
DE69837038D1 (de) | 2007-03-22 |
US20030158393A1 (en) | 2003-08-21 |
EP1813607A2 (en) | 2007-08-01 |
US20050276754A1 (en) | 2005-12-15 |
EP0971748A2 (en) | 2000-01-19 |
US7268220B2 (en) | 2007-09-11 |
US6936700B2 (en) | 2005-08-30 |
US20080227961A1 (en) | 2008-09-18 |
WO1998043678B1 (en) | 1999-04-01 |
US6177551B1 (en) | 2001-01-23 |
CA2284653C (en) | 2008-07-29 |
US6005083A (en) | 1999-12-21 |
WO1998043678A3 (en) | 1999-03-04 |
EP1813607A3 (en) | 2007-08-15 |
CA2284653A1 (en) | 1998-10-08 |
US6528627B1 (en) | 2003-03-04 |
JP2002500629A (ja) | 2002-01-08 |
EP0971748B1 (en) | 2007-02-07 |
ES2281927T3 (es) | 2007-10-01 |
US7674886B2 (en) | 2010-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7674886B2 (en) | Bridged aromatic substituted amine ligands with donor atoms | |
US5175343A (en) | Metal radionuclide labeled proteins for diagnosis and therapy | |
US4897255A (en) | Metal radionuclide labeled proteins for diagnosis and therapy | |
JP2659351B2 (ja) | 金属キレート−蛋白質複合体を形成するための多置換ジエチレントリアミンおよびその製造方法 | |
US5037630A (en) | Metal radionuclide labeled proteins for diagnosis and therapy | |
US5242679A (en) | Metal radionuclide labeled proteins for diagnosis and therapy | |
US5302370A (en) | Chelating agents for forming complexes with radioactive isotopes, metal complexes thereof and use thereof in diagnosis and therapy | |
US5202451A (en) | Anchimeric radiometal chelating compounds | |
JPH075527B2 (ja) | 二官能性dtpa型リガンド | |
US5756685A (en) | Protein conjugate containing metal radionuclide labeled proteins | |
US5120526A (en) | Method of producing metal radionuclide labeled proteins for diagnosis and therapy | |
HUT73665A (en) | Bifunctional-chelating agents braked with calcogene atoms, pharmaceutical compositions containing them , and use of these compositions in radio- diagnosis and radiotherapy | |
IE920761A1 (en) | Chelates, their metal complexes as well as their use in¹diagnosis and treatment | |
US20240018110A1 (en) | Radiolabeled compounds targeting the prostate-specific membrane antigen | |
CA2062483A1 (en) | Chelates, their metal complexes as well as their use in diagnosis and treatment | |
US6024937A (en) | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging | |
EP0759913B1 (en) | Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging | |
AU692153B2 (en) | Type S3N2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use | |
RU2655965C2 (ru) | Способ получения комплекса технеция-99м с модифицированными специфичными мини-антителами для диагностики онкологических заболеваний с гиперэкспрессией her2/neu | |
HUT73489A (en) | Chelators of type xn1s1x' braked with twovalent calcogene atom for radioactive isotopes, their metal complexes and their diagnostic and therpeutical uses, and pharmaceutical compositions containing them, and process for producing them | |
CA2031528C (en) | Radionuclide metal chelates for the radiolabeling of proteins | |
KR0153501B1 (ko) | 오르토 결합 작용기를 갖는 킬란트 및 그의 착물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: B1 Designated state(s): CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
ENP | Entry into the national phase |
Ref document number: 2284653 Country of ref document: CA Ref country code: CA Ref document number: 2284653 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 1998 541768 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1998912032 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1998912032 Country of ref document: EP |
|
WWG | Wipo information: grant in national office |
Ref document number: 1998912032 Country of ref document: EP |